Valuation: Bonesupport Holding AB

Market Cap 21.2B 2.16B 1.93B 1.78B 1.61B 3.02B 205B 3.07B 8.48B 108B 8.11B 7.93B 343B P/E 2026 *
65.3x
P/E 2027 * 41.2x
Enterprise Value 20.65B 2.1B 1.88B 1.73B 1.57B 2.94B 200B 2.99B 8.27B 105B 7.9B 7.73B 334B EV / Sales 2026 *
13.6x
EV / Sales 2027 * 10.1x
Free-Float
89.54%
Yield 2026 *
0.45%
Yield 2027 * 0.69%
1 day+1.31%
1 week+1.63%
Current month+42.79%
1 month+39.97%
3 months+47.06%
6 months+53.01%
Current year+72.87%
1 week 313.4
Extreme 313.4
340.2
1 month 218.6
Extreme 218.6
340.2
Current year 165
Extreme 165
340.2
1 year 165
Extreme 165
340.2
3 years 139.5
Extreme 139.5
405.8
5 years 34.2
Extreme 34.2
405.8
10 years 9.04
Extreme 9.04
405.8
Manager TitleAgeSince
Chief Executive Officer 49 01/09/2025
Director of Finance/CFO 63 01/11/2018
Chief Operating Officer 51 01/12/2021
Director TitleAgeSince
Director/Board Member 68 01/01/2010
Chairman 70 15/12/2016
Chairman 71 14/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/8/26 Buy

Public Communications Manager

170 0.0003%
26/8/26 Buy

Director

30 0.0000%
20/7/26 Buy

Chief Executive Officer

1,950 0.0030%
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%+1.63%+44.57%+129.36% 2.12B
+3.19%+8.48%+74.25%+153.03% 1,224B
-0.73%+2.09%+46.41%+87.64% 662B
+1.41%+3.40%+30.98%+112.26% 514B
+0.42%+2.88%+54.92%+69.67% 388B
+2.18%+1.55%+72.70%+45.42% 361B
+1.12%+3.80%+35.82%+59.72% 302B
+6.96%+7.55%+11.15%+37.89% 271B
+1.15%+4.19%+59.72%+78.16% 249B
+3.06%+8.58%+44.03%+122.76% 205B
Average +1.81%+2.36%+47.45%+89.59% 417.9B
Weighted average by Cap. +1.28%+3.04%+53.35%+100.43%

Financials

2026 *2027 *
Net sales 1.52B 155M 139M 128M 116M 216M 14.71B 220M 609M 7.73B 581M 569M 24.58B 2.02B 206M 184M 169M 153M 287M 19.51B 292M 807M 10.25B 771M 755M 32.6B
Net income 328M 33.45M 29.94M 27.56M 24.95M 46.71M 3.18B 47.53M 131M 1.67B 126M 123M 5.31B 520M 53.04M 47.48M 43.7M 39.57M 74.07M 5.04B 75.37M 208M 2.65B 199M 195M 8.41B
Net Debt -541M -55.17M -49.38M -45.46M -41.16M -77.04M -5.24B -78.4M -217M -2.75B -207M -203M -8.75B -867M -88.39M -79.12M -72.83M -65.94M -123M -8.39B -126M -347M -4.41B -332M -325M -14.02B
Projected Income Statement - Annual - Bonesupport Holding AB
Logo Bonesupport Holding AB
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Employees
174
Date Price Change Volume
30/10/26 SEK 325.00 +1.31% 247,354
29/10/26 SEK 320.80 +0.63% 339,701
28/10/26 SEK 318.80 -1.30% 434,013
27/10/26 SEK 323.00 -4.72% 584,937
26/10/26 SEK 339.00 +1.92% 805,778
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bonesupport Holding AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
325.00SEK
Average target price
374.67SEK
Spread / Average Target
+15.28%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bonesupport Holding AB
  1. Stock Market
  2. Stocks
  3. BONEX Stock